Description
The District seeks an FDA‑cleared umbilical line securement device suitable for neonates, micro‑preemies, and fragile‑skin patients. The award will be an IDIQ contract with a three‑year base term and two one‑year options. The vendor must provide ten units at no cost for a 60‑day clinical evaluation, along with instructions, training, and documentation. Pricing must be submitted on a prescribed Excel schedule and remain firm for 180 days. The solicitation is a best‑value procurement, with price weighted at 10 % and three non‑price factors each weighted at 30 %.
• Provide a multi‑size, FDA‑cleared umbilical catheter securement device for neonatal use.
• Supply 10 free units for a 60‑day clinical trial, then potentially deliver additional quantities under the IDIQ.
• Meet extensive compliance requirements (Symplr credentialing, insurance, M/WBE participation, boycott certifications, and possible TEC Form 1295).